LigaChem Biosciences
Korea - DaejeonBiotechnology
Focus: LigaChem Biosciences is a Korean biotech company specializing in ADC (Antibody-Drug Conjugate), antibiotics, anticoagulants, and anti-cancer therapeutics with focus on oncology. Limited public visibility suggests an emerging or privately-held operation.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About LigaChem Biosciences
AI assessmentNot HiringNo open roles listed right now. Follow LigaChem Biosciences to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
16 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
LCB01-0371 Tablet 800 mg
HealthyClinical Trials (1)
NCT02538003To Evaluate the Effect of Food on Pharmacokinetics(PK), Phase I Clinical Study of LCB01-0371
Phase 1Help build intelligence for LigaChem Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.